Ikeda et al., 2002 - Google Patents
Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in …Ikeda et al., 2002
View PDF- Document ID
- 2964759686544743557
- Author
- Ikeda M
- Yi M
- Li K
- Lemon S
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
Dicistronic, selectable subgenomic replicons derived from the Con1 strain of hepatitis C virus (HCV) are capable of autonomous replication in cultured Huh7 cells (Lohmann et al., Science 285: 110-113, 1999). However, adaptive mutations in the NS3, NS5A, and/or NS5B …
- 229920000160 (ribonucleotides)n+m 0 title abstract description 150
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense
- C12N2770/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA Viruses positive-sense ssRNA Viruses positive-sense
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ikeda et al. | Selectable subgenomic and genome-length dicistronic RNAs derived from an infectious molecular clone of the HCV-N strain of hepatitis C virus replicate efficiently in cultured Huh7 cells | |
Yi et al. | Adaptive mutations producing efficient replication of genotype 1a hepatitis C virus RNA in normal Huh7 cells | |
Zhu et al. | Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells | |
Tscherne et al. | Superinfection exclusion in cells infected with hepatitis C virus | |
Blight et al. | Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture | |
Yi et al. | 3′ nontranslated RNA signals required for replication of hepatitis C virus RNA | |
Blight et al. | Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication | |
Egger et al. | Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex | |
Guo et al. | Effect of alpha interferon on the hepatitis C virus replicon | |
Pietschmann et al. | Persistent and transient replication of full-length hepatitis C virus genomes in cell culture | |
Zhao et al. | Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection | |
Yi et al. | Structure–function analysis of the 3′ stem-loop of hepatitis C virus genomic RNA and its role in viral RNA replication | |
Shimakami et al. | Effect of interaction between hepatitis C virus NS5A and NS5B on hepatitis C virus RNA replication with the hepatitis C virus replicon | |
Cai et al. | Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells | |
Schaller et al. | Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes | |
Lohmann et al. | Viral and cellular determinants of hepatitis C virus RNA replication in cell culture | |
Wakita et al. | Production of infectious hepatitis C virus in tissue culture from a cloned viral genome | |
Xiang et al. | Full-length GB virus C (Hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells | |
Krieger et al. | Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations | |
Gale Jr et al. | Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase | |
Lindenbach et al. | Complete replication of hepatitis C virus in cell culture | |
Bartenschlager | Hepatitis C virus replicons: potential role for drug development | |
Gottwein et al. | Novel infectious cDNA clones of hepatitis C virus genotype 3a (strain S52) and 4a (strain ED43): genetic analyses and in vivo pathogenesis studies | |
Kanda et al. | Generation of infectious hepatitis C virus in immortalized human hepatocytes | |
JP4903929B2 (en) | Hepatitis C virus cell culture system, hepatitis C virus-RNA-construct, use of cell culture system or construct, method for obtaining mutants compatible with hepatitis C virus-RNA-construct cell culture, hepatitis C Method for making a virus-full-length genome, hepatitis C virus-partial genome, or any hepatitis C virus-construct mutant, hepatitis C virus-construct adapted for cell culture, mutant thereof, hepatitis C virus -Full-length genome mutants, hepatitis C virus particles or virus-like particles, and cells infected therewith |